Stock Events

Stock Events

Medicure 

$2.50
3
-$0.32-11.28%Friday 20:57

Statistics

Day High
3
Day Low
2.08
52W High
3.45
52W Low
0.67
Volume
18,033
Avg. Volume
13,384
Mkt Cap
26.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 25Expected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-24.71%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
20.8MRevenue
-5.14MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap251.94B
Amgen develops and produces medications in similar therapeutic areas as Medicure, including cardiovascular drugs.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that manufactures drugs like Entresto, competing in the cardiovascular market.
Pfizer
PFE
Mkt Cap173.95B
Pfizer produces a range of cardiovascular treatments, directly competing with Medicure's heart health products.
Merck
MRK
Mkt Cap368.89B
Merck & Co. offers cardiovascular therapies, including Zetia and Vytorin, which compete in the same space as Medicure.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol-Myers Squibb produces cardiovascular drugs, competing directly with Medicure's product offerings.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie, through its acquisition of Allergan, has expanded into cardiovascular treatments, competing with Medicure.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca has a strong portfolio in cardiovascular diseases, including drugs like Brilinta, competing with Medicure.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly and Company competes in the cardiovascular market, which overlaps with Medicure's therapeutic focus.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline produces medications for heart diseases, competing in the same therapeutic areas as Medicure.
Sanofi
SNY
Mkt Cap106.24B
Sanofi offers a range of cardiovascular treatments, directly competing with Medicure in this therapeutic area.

About

Medicure Inc. is a biopharmaceutical firm focused on developing, researching, and commercializing therapeutic solutions for cardiovascular conditions across Canada and the United States. Its product portfolio includes AGGRASTAT, an injectable glycoprotein GP IIb/IIIa receptor antagonist prescribed for acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction. The company also provides ZYPITAMAG, a medication used to manage primary hyperlipidemia and mixed dyslipidemia. Additionally, Medicure offers the ReDS system, a non-invasive medical device designed to measure lung fluid levels, aiding in the management of congestive heart failure. Another key offering is Sodium Nitroprusside injection, utilized for rapidly lowering blood pressure during hypertensive crises in both adult and pediatric patients, inducing controlled hypotension for surgical bleeding reduction, and treating acute congestive heart failure. These products are made available through both retail pharmacy networks and online platforms. Established in 1997, Medicure Inc. is headquartered in Winnipeg, Canada.
Show More
CEO
Albert David Friesen
Employees
25
Country
Canada
ISIN
CA58469E4085
WKN
000A1J7TZ

Listings

MU
DE
NGQ1.MU
STU
DE
NGQ1.STU
V
CA
MPH.V
F
DE
NGQ1.F

0 Comments

Share your thoughts

FAQs

What is Medicure stock price today?▼
The current price of MCUJF is $2.50 USD — it has decreased by -11.28% in the past 24 hours. Watch Medicure stock price performance more closely on the chart.
What is Medicure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Medicure stocks are traded under the ticker MCUJF.
Is Medicure stock price growing?▼
MCUJF stock has fallen by -20.13% compared to the previous week, the month change is a +19.05% rise, over the last year Medicure has showed a +177.78% increase.
What is Medicure market cap?▼
Today Medicure has the market capitalization of 26.09M
When is the next Medicure earnings date?▼
Medicure is going to release the next earnings report on November 25, 2026.
What is Medicure revenue for the last year?▼
Medicure revenue for the last year amounts to 20.8M USD.
What is Medicure net income for the last year?▼
MCUJF net income for the last year is -5.14M USD.
How many employees does Medicure have?▼
As of November 8, 2026, the company has 25 employees.
In which sector is Medicure located?▼
Medicure operates in the Health & Wellness sector.
When did Medicure complete a stock split?▼
The last stock split for Medicure was on November 2, 2012 with a ratio of 1:15.
Where is Medicure headquartered?▼
Medicure is headquartered in Winnipeg, Canada.